Early detection of antibodies against rDNA-produced HIV proteins with a flow cytometric assay.

There is evidence that some human immunodeficiency virus (HIV)-infected individuals have prolonged periods of seronegativity. A flow cytometric immunoreactive bead (IRB) assay is described for quantitative, simultaneous, and early detection of antibodies to HIV. Polystyrene beads of four diameters, each size coated with a different HIV recombinant DNA-produced protein (p24, p31, gp41, or gp120), bound anti-HIV antibodies detected with fluorescent antiglobulin. The IRB assay was performed on a panel of blood donor samples, many giving consistently false-positive enzyme immunoassay (EIA) and indeterminant Western blot (WB) results. The IRB assay proved as sensitive and more specific than currently licensed EIA and WB tests. Results on serial samples from eight HIV-infected individuals indicated that quantitation of anti-p24 by IRB assay may be useful in monitoring disease progression. Sequential pre- and post-EIA seroconversion sera from 35 HIV-infected homosexual men were tested by the IRB assay using IgM- and IgG-specific fluorescent probes. All 35 cases were IRB assay positive for at least one rDNA-p either before (17 of 35, 49%) or at the time of EIA positivity. Eleven cases (31%) initially had only IgM anti-HIV, primarily to gp41 (17%). In two individuals, the IgM response was detected at least 18 months before EIA seroconversion. The IRB assay is a widely applicable analytic procedure, potentially useful in pretransfusion anti-HIV screening of blood.

[1]  K. Steimer,et al.  Recombinant polypeptide from the endonuclease region of the acquired immune deficiency syndrome retrovirus polymerase (pol) gene detects serum antibodies in most infected individuals , 1986, Journal of virology.

[2]  T. Zuck.  Transfusion-transmitted AIDS reassessed. , 1988, The New England journal of medicine.

[3]  G. Frösner,et al.  IMMUNOBLOT TEST WITH RECOMBINANT HIV ANTIGENS , 1987, The Lancet.

[4]  M. Busch,et al.  Assessment of human immunodeficiency virus expression in cocultures of peripheral blood mononuclear cells from healthy seropositive subjects , 1988, Journal of medical virology.

[5]  E. Berto,et al.  HIV IgM ANTIBODIES IN RISK GROUPS WHO ARE SERONEGATIVE ON ELISA TESTING , 1986, The Lancet.

[6]  J. Esteban,et al.  IMPORTANCE OF WESTERN BLOT ANALYSIS IN PREDICTING INFECTIVITY OF ANTI-HTLV-III/LAV POSITIVE BLOOD , 1985, The Lancet.

[7]  J. Nelson,et al.  Diagnosis of AIDS by using a 12-amino acid peptide representing an immunodominant epitope of the human immunodeficiency virus. , 1987, The Journal of infectious diseases.

[8]  R. Redfield,et al.  Diagnosis of Human Immunodeficiency Virus Infection by Immunoassay Using a Molecularly Cloned and Expressed Virus Envelope Polypeptide: Comparison to Western Blot on 2707 Consecutive Serum Samples , 1987 .

[9]  P. Imperato.  Public Health Service guidelines for counseling and antibody testing to prevent HIV infection and AIDS. , 1987, MMWR. Morbidity and mortality weekly report.

[10]  G. Dawson,et al.  Antigenemia and antibody titers to core and envelope antigens in AIDS, AIDS-related complex, and subclinical human immunodeficiency virus infection. , 1987, The Journal of infectious diseases.

[11]  J. Levy,et al.  Evaluation of the indirect immunofluorescence assay as a confirmatory test for detecting antibodies to the human immunodeficiency virus. , 1986, Diagnostic immunology.

[12]  J H Jett,et al.  Amplified flow-cytometric separation-free fluorescence immunoassays. , 1985, Clinical chemistry.

[13]  C Y Ou,et al.  DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells. , 1988, Science.

[14]  J. Menitove,et al.  FALSE-POSITIVE ANTI-HIV TESTS AND BLOOD DONATION , 1987, The Lancet.

[15]  H. Balfour,et al.  Practical diagnostic testing for human immunodeficiency virus , 1988, Clinical Microbiology Reviews.

[16]  R. Gallo,et al.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. , 1984, Science.

[17]  J. Ward,et al.  Transmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibody. , 1988, The New England journal of medicine.

[18]  S. Kleinman,et al.  Follow‐up testing and notification of anti‐HIV Western blot atypical (indeterminant) donors , 1988, Transfusion.

[19]  K. Steimer,et al.  Differential antibody responses of individuals infected with AIDS-associated retroviruses surveyed using the viral core antigen p25gag expressed in bacteria. , 1986, Virology.

[20]  K. Steimer,et al.  Antigenicity and immunogenicity of domains of the human immunodeficiency virus (HIV) envelope polypeptide expressed in the yeast Saccharomyces cerevisiae. , 1987, Vaccine.

[21]  M. Leuther,et al.  LONG LATENCY PRECEDES OVERT SEROCONVERSION IN SEXUALLY TRANSMITTED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION , 1987, The Lancet.

[22]  R. Redfield,et al.  False-positive Western blot tests for antibodies to HTLV-III. , 1986, JAMA.

[23]  G. Luzi,et al.  DELAYED APPEARANCE OF HIV INFECTION IN CHILDREN , 1987, The Lancet.

[24]  J. Goudsmit,et al.  Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS. , 1986, British medical journal.

[25]  J. Parry,et al.  PLACE OF IgM ANTIBODY TESTING IN HIV SEROLOGY , 1986, The Lancet.

[26]  C. Griscelli,et al.  Detection of HIV1 DNA in infants and children by means of the polymerase chain reaction. , 1988, Lancet.

[27]  D. Tribe,et al.  Evaluation of atypical human immunodeficiency virus immunoblot reactivity in blood donors , 1988, Transfusion.

[28]  J. Levy,et al.  Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. , 1984, Science.

[29]  S. J. Potter,et al.  Molecular cloning of AIDS-associated retrovirus , 1984, Nature.

[30]  J. Parry,et al.  Diagnostic value of specific IgM antibodies in primary HIV infection. , 1988, AIDS.

[31]  L. Wheeless,et al.  Quantitative single cell analysis and sorting. , 1977, Science.

[32]  J. Chermann,et al.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). , 1983, Science.

[33]  H. Reesink,et al.  BLOOD DONATIONS REACTIVE FOR HIV IN WESTERN BLOT, BUT NON-INFECTIVE IN CULTURE AND RECIPIENTS OF BLOOD , 1986, The Lancet.

[34]  Y. Laurian,et al.  SEROLOGICAL MARKERS IN EARLY STAGES OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN HAEMOPHILIACS , 1986, The Lancet.

[35]  J. Albert,et al.  ANTIBODY RESPONSE IN PRIMARY HUMAN IMMUNODEFICIENCY VIRUS INFECTION , 1987, The Lancet.

[36]  J. Levy,et al.  Clinical, immunologic, and serologic findings in men at risk for acquired immunodeficiency syndrome. The San Francisco Men's Health Study. , 1987, JAMA.

[37]  L. Epstein,et al.  EXPRESSION OF HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN (HIV-Ag) IN SERUM AND CEREBROSPINAL FLUID DURING ACUTE AND CHRONIC INFECTION , 1986, The Lancet.

[38]  B. Mach,et al.  IDENTIFICATION OF HIV-INFECTED SERONEGATIVE INDIVIDUALS BY A DIRECT DIAGNOSTIC TEST BASED ON HYBRIDISATION TO AMPLIFIED VIRAL DNA , 1988, The Lancet.

[39]  P. Grob,et al.  Anti-HIV IgM antibody analysis during early manifestations of HIV infections. , 1987, AIDS.